表紙
市場調查報告書

注射器市場 - 成長,趨勢,預測(2019年∼2024年)

Syringe Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 851141
出版日期 內容資訊 英文 113 Pages
商品交期: 2-3個工作天內
價格
Back to Top
注射器市場 - 成長,趨勢,預測(2019年∼2024年) Syringe Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年04月01日內容資訊: 英文 113 Pages
簡介

本報告提供注射器的世界市場調查,市場概要,各類型,各地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
  • 市場阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各使用
    • 殺菌、可重複使用類型
    • 拋棄式類型
    • 預填充式注射器
  • 各用途
    • 胰島素注射
    • 肉毒桿菌
    • 骨關節炎
    • 人體生長荷爾蒙
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東&非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Becton Dickinson and Company.
    • B. Braun Melsungen AG.
    • Gerresheimer AG.
    • Hindustan Syringes & Medical Devices Limited
    • Terumo Corporation.
    • Nipro Corporation.
    • Schott AG.
    • Cardinal Health.
    • Smiths Medical.
    • Codan Medizinische Gerte GmbH & Co. KG.
    • Catalent Inc.

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 58869

Market Overview

The syringe market is expected to witness a robust growth owing to several factors, such as the rise in the demand for pre-filled syringes, growing prevalence of chronic diseases, such as diabetes, and increase in the usage of Botox for therapeutic applications. Moreover, the increased adoption of injectable drugs, technological advancements in syringes, increase in geriatric population, growing number of vaccination and immunization programs are expected to drive the volume growth over the next few years. According to WHO estimates, around 16 billion injections are administered globally on an annual basis. On the other hand, the rise in incidence of needle-stick injuries, high cost associated with safety syringes, and disposable syringes are likely to hinder the growth of the syringe market globally.

Scope of the Report

The syringe is a device used by medical professionals to transfer liquids into or out of the body. It is made up of a hollow needle, which is attached to a tube and a plunger. When the plunger handle is pulled back, fluids are drawn into the tube. The fluid is forced out through the needle when the handle is pushed down. The syringe was introduced in the mid-1800s and has steadily improved with the development of new materials and designs.

Key Market Trends

Prefilled syringes are anticipated to dominate the market

The syringe market is segmented on the basis of usage and application. By usage, the market is further segmented into sterilizable/reusable syringes, disposable syringes, and prefilled syringes.

Prefilled syringes are gaining acceptance in the market as drug delivery systems designed for injectable drugs. They are generally preferred for parenteral administration of various drugs and are used mainly for the treatment of chronic diseases where patients have to administer medication themselves, several times a week. In line with this trend, many pharmaceutical companies are focusing on bringing in advancements in self-administration therapies. For instance, the EpiPen auto-injector and similarly in July 2016, Bristol-Myers Squibb commercially launched the ORENCIA Clickject auto-injector. The latest trend gaining momentum in the market is the shift from glass prefilled syringes to plastic pre-filled syringes. The plastic prefilled syringes are becoming more popular due to the introduction of advanced polymer materials, such as polypropylene and crystal-clear polymer, which are biocompatible with the other components of the syringe.

Asia-Pacific is anticipated to grow rapidly in the syringe market

The Asia-Pacific market for syringes is anticipated to exhibit a strong growth during the forecast period. Although the syringe market is presently in its stage of infancy in APAC, factors, such as improving economic conditions, rise in purchasing power of the people, the growth in awareness regarding the advantages of prefilled syringes, and the presence of a large patient pool suffering from various chronic diseases are expected to drive the market to register a double-digit CAGR. In Asia-Pacific, Japan accounts for the major share of the market by revenue as well as volume, owing to the increased demand for self-administered treatments and high penetration of self-injection devices, growing the aging population, and increasing the prevalence of diabetes.

Competitive Landscape

The syringe market is highly fragmented with the presence of a large number of local and international players. Key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. For instance, in April 8, 2019 - Fresenius Kabi launched Adenosine Injection, USP in 6 mg per 2 mL and 12 mg per 4 mL single dose in Simplist® ready-to-administer prefilled syringes in the United States. In October 2018- W. L. Gore & Associates, Inc. (a global materials science company) launched the GORE™ ImproJect™ Plunger for pre-filled syringes. In November 2018- Septodont launched the Dentapen electronic syringe for dental anesthesia.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Prevalence of Chronic Diseases
    • 4.2.2 Increased Adoption of Injectable Drugs
    • 4.2.3 Technological Advancements in Syringes
  • 4.3 Market Restraints
    • 4.3.1 Increasing Incidence of Needle-stick Injuries, Coupled with High Cost of Safety Syringes
    • 4.3.2 Availability of Alternate Drug Delivery Methods
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Usage
    • 5.1.1 Sterilizable/Reusable Syringes
    • 5.1.2 Disposable Syringes
    • 5.1.3 Prefilled Syringes
  • 5.2 Application
    • 5.2.1 Insulin Syringes
    • 5.2.2 Botox
    • 5.2.3 Osteoarthritis
    • 5.2.4 Human Growth Hormone
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton Dickinson and Company.
    • 6.1.2 B. Braun Melsungen AG.
    • 6.1.3 Gerresheimer AG.
    • 6.1.4 Hindustan Syringes & Medical Devices Limited
    • 6.1.5 Terumo Corporation.
    • 6.1.6 Nipro Corporation.
    • 6.1.7 Schott AG.
    • 6.1.8 Cardinal Health.
    • 6.1.9 Smiths Medical.
    • 6.1.10 Codan Medizinische Gerte GmbH & Co. KG.
    • 6.1.11 Catalent Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top